05:39 , Jan 19, 2018 |  BC Week In Review  |  Financial News

HalioDx raises first tranche of €18.5M series B

Diagnostic company HalioDx S.A.S. (Marseille, France) raised €9.25 million ($11.3 million) on Jan. 17 in the first tranche of a €18.5 million ($22.6 million) series B round led by new investor PSIM. Other new investors...
05:54 , Jan 17, 2018 |  BC Extra  |  Financial News

HalioDx raises first tranche of €18.5M series B

Diagnostic company HalioDx S.A.S. (Marseille, France) raised €9.25 million ($11.3 million) in the first tranche of a €18.5 million ($22.6 million) series B round led by new investor PSIM. Other new investors Quest for Growth...
21:04 , Jul 28, 2017 |  BC Week In Review  |  Clinical News

Reata reports Phase II data for bardoxolone methyl in CKD

Reata Pharmaceuticals Inc. (NASDAQ:RETA) reported data from 30 patients with chronic kidney disease (CKD) caused by Alport syndrome in the open-label Phase II portion of the Phase II/III CARDINAL trial showing that once-daily oral bardoxolone...
22:44 , Jul 24, 2017 |  BC Extra  |  Clinical News

Reata gains as bardoxolone study moves to Phase III

Reata Pharmaceuticals Inc. (NASDAQ:RETA) gained $4.37 (14%) to $35.47 on Monday after saying it will move ahead to the Phase III portion of the Phase II/III CARDINAL study of bardoxolone methyl ( RTA 402 )...
19:54 , Apr 3, 2017 |  BC Extra  |  Company News

Ogeda takeout gives Astellas hot flashes candidate

Astellas Pharma Inc. (Tokyo:4503) is acquiring Ogeda S.A. (Gosselies, Belgium), giving the pharma neurokinin 3 receptor ( TACR3 ; NK3R) antagonist fezolinetant ( ESN364 ). The candidate has met the primary endpoints in a Phase...
12:51 , Mar 9, 2017 |  BC Week In Review  |  Financial News

Thermo Fisher completes private placement of senior notes

On March 7, life sciences supplier Thermo Fisher Scientific Inc. (NYSE:TMO) raised €500 million ($531.3 million) through the sale of 1.45% senior notes due in 2027. Credit Suisse Securities, HSBC Bank, BNP Paribas, Citigroup, Deutsche...
22:07 , Dec 9, 2016 |  BC Week In Review  |  Financial News

Zimmer Biomet completes private placement of senior notes

Zimmer Biomet raised €1 billion ($1.1 billion) in senior unsecured notes comprising €500 million ($531.9 million) in 1.414% notes due in 2022 and €500 million in 2.425% notes due in 2026. BNP Paribas, HSBC, RBC...
00:30 , Dec 2, 2016 |  BC Extra  |  Financial News

V-Bio closes EUR 76M fund

V-Bio Ventures closed its first life sciences fund at EUR 76 million ($81 million). LPs include the European Investment Fund (EIF), PMV-ARKimedes, Korys, KU Leuven, Gimv, SFPI-FPIM, BNP Paribas Fortis Private Equity and Ghent University...
07:00 , Sep 19, 2016 |  BC Week In Review  |  Financial News

Thermo Fisher completes private placement of senior notes

Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass.   Business: Supply/Service   Date completed: 2016-09-07   Type: Private placement of senior notes   Raised: EUR1.6 billion ($1.8 billion)   Underwriters: JPMorgan; Mizuho; Barclays Capital; BNP Paribas;...
07:00 , Sep 19, 2016 |  BC Week In Review  |  Financial News

Thermo Fisher completes private placement of senior notes

Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass.   Business: Supply/Service   Date completed: 2016-09-14   Type: Private placement of senior notes   Raised: $1.2 billion   Underwriters: JPMorgan; Citigroup; Deutsche Bank; Barclays Capital; Merrill Lynch,...